Katsumi Takeuchi,Chairman of Daifuku Co.,Ltd.,passed away from heart failure on Tuesday,January 8 in Tokyo,Japan,at the age of 73. Takeuchi has shown his great ability as the Chairman and Co-CEO of the Daifuku Group.Takeuchi was born ...
Tags: Daifuku, Chairman, heart failure
CardioKinetix has completed enrolling the first patient in PARACHUTE IV trial of its Parachute ventricular partitioning device for treating heart failure patients. The minimally invasive device is deployed into the left ventricle to ...
Thoratec has gained an investigational device exemption(IDE)from the US Food and Drug Administration(FDA)for the initiation of a feasibility clinical study of its continuous-flow left ventricular assist device(LVAD),for the treatment of ...
BG Medicine has obtained CE mark certification for its automated Galectin-3 blood test, designed for the management of chronic heart failure. The test will be made available through bioMerieux's VIDAS immunoassay, which consists of about ...
Tags: EU, CE Mark, BG Medicine, Medicine
Atherotech Diagnostics Lab, a CLIA-certified clinical reference laboratory, has entered into an agreement to offer BG Medicine's galectin-3 testing services to laboratory customers and physicians. To offer the services, Atherotech is ...
BioVentrix has launched a myocardial anchoring system for patients with ischemic cardiomyopathy. The new technology, Revivent, is designed for use in less invasive ventricular enhancement (LIVE) procedures to improve the function of ...
St Jude Medical has launched Unify Quadra cardiac resynchronization therapy defibrillator (CRT-D) in Japan. The Unify Quadra CRT-D features four electrodes to provide physician with more pacing options and the ability to pace closer ...
Tags: St Jude Medical, cardiac resynchronization therapy, medical technology
Sunshine Heart has obtained a conditional approval from the US Food and Drug Administration (FDA) for its investigational device exemption (IDE)) implantable heart assist device. The non-blood contacting C-Pulse Heart Assist device, ...
Tags: C-Pulse IDE Device, FDA, clinical trial
Sunshine Heart has submitted an investigational device exemption (IDE) application of its C-Pulse Heart Assist system to the US Food and Drug Administration (FDA) for approval. The basis of the IDE application is for the initiation of ...
Tags: FDA, medical system, medical technology
Sorin Group, a manufacturer of medical technologies for cardiac surgery, has purchased Neurotech to expand its market of neuromodulation therapies for treating heart failure. Neurotech's commercial products include implantable medical ...
Tags: cardiac surgery, medical technology, expansion, medical device
Sunshine Heart is planning to initiate a US pivotal trial on its C-Pulse Heart Assist device in the fourth quarter of 2012, as it received an unconditional approval from the US Food Drug Administration (FDA). The CE marked system, ...
Tags: FDA, clinical trial, medical system
CardioKinetix has reported positive three-year clinical data of its minimally invasive Parachute ventricular partitioning device, following Percutaneous Ventricular Restoration therapy in heart failure patients. The Parachute device, ...
Tags: CardioKinetix, clinical data, Parachute, ventricular partitioning device
Medtronic has gained CE mark for its Viva/Brava portfolio of cardiac resynchronization therapy with defibrillation (CRT-D) devices. The family of CRT-Ds features a new algorithm, called AdaptivCRT, which by preserving patients' normal ...
Tags: Medtronic, CE mark, CRT-D devices, AdaptivCRT, CRT treatment
Biotronik is set to showcase its magnetic resonance imaging (MRI) approved implantable heart failure devices at the European Society of Cardiology congress, being held between 25-29 August 2012. The MRI-approved devices include Lumax 740 ...
Tags: Biotronik, MRI, heart failure devices, MRI-approved devices, CRT-D, CRT-P
CardioKinetix has started enrolling patients for its PARACHUTE III, a post-market safety surveillance trial, in Germany. The dual-arm, multi-center, open-label trial, which will enroll up to 100 ischemic heart failure patients, is ...